Fibroblast-activation protein inhibitors based positron emission tomography (PET) for assessing lung disease: A systematic review with meta-analysis - PubMed
a day ago
- #FAPI PET/CT
- #lung disease diagnosis
- #meta-analysis
- Fibroblast-activation protein inhibitors (FAPI) based PET shows high sensitivity and specificity for diagnosing lung diseases.
- Meta-analysis of 19 studies reveals FAPI PET/CT has 0.99 sensitivity and 0.82 specificity for lung tumors.
- FAPI PET/CT demonstrates 0.93 sensitivity and 0.96 specificity for non-neoplastic lung lesions.
- Subgroup analysis highlights FAPI PET/CT's effectiveness in lung tumor staging and diagnosing pneumonia and idiopathic pulmonary fibrosis.
- Current CT limitations in assessing lung disease activity may delay diagnosis, suggesting FAPI PET/CT's clinical utility.